|
|
Bibliometric analysis of Danhong Injection based on CiteSpace |
LIAN Yanjie1 LIU Hongxu1 WU Cong1 ZHOU Mingxue2 KONG Jinli1 |
1.Department of Cardiovascular Disease, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China;
2.Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China |
|
|
Abstract Objective To explore the development status and research hotspots of Danhong Injection and predict the future research direction through bibliometrics. Methods Taking CNKI as the data source, the literatures related to Danhong Injection were retrieved from January 2010 to December 2020. CiteSpace 5.5.1 software was used to analyze the author, organization and key words of the literatures, and a visual map was drew. Results A total of 3814 documents were obtained, and four research teams and three regional research cooperation institutions were obtained through econometric analysis. “Acute cerebral infarction”, “cerebral infarction” and “coronary heart disease” were the most frequently used keywords. “Neurological function”, “cerebral infarction” and “cardiac function” were the keywords with the highest highlight intensity. The emergence intensity of keywords such as “clinical effect”, “neurological function” and “systematic evaluation” continued to today. Conclusion At present, the research focus of Danhong Injection is acute cerebral infarction and coronary heart disease, mechanism and safety may be the focus of research in the future.
|
|
|
|
|
[1] 王平,李艳,高燕,等.丹红注射液对H2O2氧化导致牛胸主动脉内皮细胞损伤的保护作用[J].中华中医药杂志,2017,32(6):2696-2699.
[2] 郭建峰,吴胜本,杨金平,等.丹红注射液对ACS患者PCI术后血管内皮功能及炎性因子水平的影响[J].中国实验方剂学杂志,2015,21(12):154-157.
[3] 赵帅,曾靖,蔡海荣,等.丹红注射液对动脉粥样硬化家兔内皮功能及肝X受体mRNA的影响[J].广州中医药大学学报,2017,34(1):64-70.
[4] 付长庚,刘龙涛,王跃飞,等.丹红注射液临床应用中国专家共识[J].中国中西医结合杂志,2018,38(4):389-397.
[5] 侯剑华,胡志刚.CiteSpace软件应用研究的回顾与展望[J].现代情报,2013,33(4):99-103.
[6] 丁学东.文献计量学基础[J].北京:北京大学出版社,1993:373.
[7] 李文兰,杨祖国.中国情报学期刊论文关键词词频分析[J].情报科学,2005(1):68-70.
[8] 赵娅,唐进法,张辉,等.丹红注射液与维生素B6注射液的配伍稳定性研究[J].中国新药杂志,2016,25(14):1647-1651.
[9] 赵娅,唐进法,李伟霞,等.丹红注射液与门冬氨酸钾镁注射液配伍在两种常用溶媒中的稳定性研究[C]//2016年第六届全国药物毒理学年会论文集.2016:356-357.
[10] 李学林,李伟霞,赵娅,等.丹红注射液与胞磷胆碱钠注射液在2种常用溶媒中的配伍稳定性[J].中国实验方剂学杂志,2017,23(3):6-9.
[11] 李伟霞,赵娅,唐进法,等.丹红注射液与奥拉西坦注射液配伍稳定性研究[J].河南中医,2018,38(7):1113-1117.
[12] 秦英,刘玉琴,李芳.丹红注射液对冠心病心绞痛患者血液流变学及炎症因子的影响[J].血栓与止血学,2020, 26(2):218-219.
[13] 宋晓蓉,谢陈玲.丹红注射液对冠心病患者血液流变学影响的临床观察[J].临床和实验医学杂志,2014,13(2):126-128.
[14] 周鹏,何昱,杨洁红,等.丹红注射液对缺氧损伤脑微血管内皮细胞的保护机制[J].中国中药杂志,2014,39(24):4844-4848.
[15] 谭莉,万芳超,刘容,等.丹红注射液对大鼠急性脑梗死后血管新生的影响[J].中医药导报,2019,25(20):71-75.
[16] 祝敬伟,齐继红.丹红注射液治疗急性脑梗死的效果及对患者神经功能、炎症因子水平的影响[J].临床医学,2020,40(2):95-97.
[17] 云红,黎嘉慧,胡方.丹红注射液对脑梗死患者脑血流动力学和血液流变学的影响[J].海南医学,2017,28(7):1059-1061.
[18] 陈刚.丹红注射液对全髋关节置换术患者血小板及血流变状态的影响[J].海南医学院学报,2014,20(11):1554-1556.
[19] 刘燕,陈晓兵,许培.丹红注射液联合依达拉奉治疗急性脑梗死的效果观察[J].当代医药论丛,2019,17(22):113-115.
[20] 池锐锋,林冰薇,林喜春.丹红注射液治疗急性脑梗死患者的效果及对患者肾功能与血管再生的影响[J].中国医学创新,2019,35(35):31-34.
[21] 王飞,徐晶晶,朱士俊,等.丹红注射液对慢性心力衰竭患者的影响[J].中国循证心血管医学杂志,2017,9(10):1229-1232.
[22] 王景.丹红注射液对老年慢性心力衰竭患者氧化应激状态及心功能的影响[J].现代中西医结合杂志,2016,25(31):3443-3445.
[23] 张玉灵,尚菊菊,邢文龙,等.丹红注射液干预择期PCI围手术期心肌保护与安全性的系统评价[J].世界中医药,2017,12(2):258-265.
[24] 董静,陈韵岱,刘红旭,等.丹红注射液对不稳定型心绞痛血瘀证患者经皮冠状动脉介入术围手术期血管内皮功能的影响[J].中医杂志,2014,55(13):1109-1112. |
|
|
|